NM_000815.5:c.1324G>A
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 1P and 4B. PP3BS2
The NM_000815.5(GABRD):c.1324G>A(p.Val442Ile) variant causes a missense change. The variant allele was found at a frequency of 0.00000498 in 1,406,802 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000050 ( 0 hom. )
Consequence
GABRD
NM_000815.5 missense
NM_000815.5 missense
Scores
2
9
8
Clinical Significance
Conservation
PhyloP100: 5.38
Publications
1 publications found
Genes affected
GABRD (HGNC:4084): (gamma-aminobutyric acid type A receptor subunit delta) Gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. The GABA-A receptor is generally pentameric and there are five types of subunits: alpha, beta, gamma, delta, and rho. This gene encodes the delta subunit. Mutations in this gene have been associated with susceptibility to generalized epilepsy with febrile seizures, type 5. Alternatively spliced transcript variants have been described for this gene, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
GABRD Gene-Disease associations (from GenCC):
- complex neurodevelopmental disorderInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics, ClinGen
- epilepsyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- epilepsy, idiopathic generalized, susceptibility to, 10Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -3 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.748
BS2
High AC in GnomAdExome4 at 7 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRD | NM_000815.5 | c.1324G>A | p.Val442Ile | missense_variant | Exon 9 of 9 | ENST00000378585.7 | NP_000806.2 | |
GABRD | XM_017000936.2 | c.2029G>A | p.Val677Ile | missense_variant | Exon 8 of 8 | XP_016856425.1 | ||
GABRD | XM_011541194.4 | c.1363G>A | p.Val455Ile | missense_variant | Exon 9 of 9 | XP_011539496.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD2 exomes AF: 0.00000926 AC: 2AN: 215922 AF XY: 0.0000171 show subpopulations
GnomAD2 exomes
AF:
AC:
2
AN:
215922
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000498 AC: 7AN: 1406802Hom.: 0 Cov.: 32 AF XY: 0.00000722 AC XY: 5AN XY: 692490 show subpopulations
GnomAD4 exome
AF:
AC:
7
AN:
1406802
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
692490
show subpopulations
African (AFR)
AF:
AC:
0
AN:
31800
American (AMR)
AF:
AC:
0
AN:
38176
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
23512
East Asian (EAS)
AF:
AC:
1
AN:
38786
South Asian (SAS)
AF:
AC:
0
AN:
79846
European-Finnish (FIN)
AF:
AC:
0
AN:
50708
Middle Eastern (MID)
AF:
AC:
0
AN:
5520
European-Non Finnish (NFE)
AF:
AC:
6
AN:
1080584
Other (OTH)
AF:
AC:
0
AN:
57870
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Idiopathic generalized epilepsy Uncertain:1
Aug 20, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Benign
N;.;.;.
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.;.;.
REVEL
Uncertain
Sift
Benign
T;.;.;.
Sift4G
Benign
T;.;.;.
Polyphen
D;.;.;.
Vest4
MutPred
Loss of catalytic residue at V442 (P = 0.0173);.;.;.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.